Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Robust radiotherapy planning
258
Zitationen
15
Autoren
2018
Jahr
Abstract
Motion and uncertainty in radiotherapy is traditionally handled via margins. The clinical target volume (CTV) is expanded to a larger planning target volume (PTV), which is irradiated to the prescribed dose. However, the PTV concept has several limitations, especially in proton therapy. Therefore, robust and probabilistic optimization methods have been developed that directly incorporate motion and uncertainty into treatment plan optimization for intensity modulated radiotherapy (IMRT) and intensity modulated proton therapy (IMPT). Thereby, the explicit definition of a PTV becomes obsolete and treatment plan optimization is directly based on the CTV. Initial work focused on random and systematic setup errors in IMRT. Later, inter-fraction prostate motion and intra-fraction lung motion became a research focus. Over the past ten years, IMPT has emerged as a new application for robust planning methods. In proton therapy, range or setup errors may lead to dose degradation and misalignment of dose contributions from different beams - a problem that cannot generally be addressed by margins. Therefore, IMPT has led to the first implementations of robust planning methods in commercial planning systems, making these methods available for clinical use. This paper first summarizes the limitations of the PTV concept. Subsequently, robust optimization methods are introduced and their applications in IMRT and IMPT planning are reviewed.
Ähnliche Arbeiten
Radiative Transfer
1950 · 8.660 Zit.
Practical cone-beam algorithm
1984 · 6.205 Zit.
Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
1995 · 4.807 Zit.
Tolerance of normal tissue to therapeutic irradiation
1991 · 4.458 Zit.
Clonogenic assay of cells in vitro
2006 · 4.122 Zit.
Autoren
Institutionen
- University Hospital of Zurich(CH)
- Heidelberg University(DE)
- University Hospital Heidelberg(DE)
- Heidelberger Institut für Radioonkologie(DE)
- German Cancer Research Center(DE)
- RaySearch Laboratories (Sweden)(SE)
- University of Toronto(CA)
- Memorial Sloan Kettering Cancer Center(US)
- Harvard University(US)
- Massachusetts General Hospital(US)
- University of Manchester(GB)
- Cancer Research UK Manchester Institute(GB)
- Mayo Clinic Hospital(US)
- Mayo Clinic in Florida(US)
- University of Waterloo(CA)
- Northwestern University(US)
- University of Virginia(US)
- The Netherlands Cancer Institute(NL)
- University of Maryland, Baltimore(US)